By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kadmon Corporation (Formerly Known As Kadmon Pharmaceuticals) 

Alexandria Center for Life Sciences
450 East 29th Street, 5th Floor
New York  New York  10016  U.S.A.
Phone: 212-308-6000 Fax: n/a




Company News
Kadmon Corporation Initiates Second Phase 2 Clinical Trial Evaluating KD026 In Type 2 Diabetes 5/4/2015 9:10:57 AM
Kadmon Corporation Launches New Gene Therapy Subsidiary 5/1/2015 7:46:16 AM
Kadmon Corporation Presents Encouraging Nonclinical Data On Tesevatinib (KD019) At AACR Annual Meeting 4/23/2015 1:26:16 PM
Kadmon Corporation To Present At Two Upcoming Investor Conferences 3/20/2015 11:18:00 AM
Kadmon Corporation Announces Publication Highlighting Importance Of ROCK2 In Autoimmunity 2/9/2015 12:12:26 PM
Kadmon Corporation To Present At CBI's 12th Annual Pharmaceutical Compliance Congress 1/27/2015 12:51:15 PM
Kadmon Corporation To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/7/2015 12:15:54 PM
Kadmon Corporation Initiates Phase 2 Clinical Trial Evaluating KD025 In Psoriasis 1/7/2015 10:59:02 AM
Kadmon Corporation's KD025 Named A Top Priority Lupus Treatment Candidate By The Alliance For Lupus Research And The Lupus Research Institute 12/12/2014 11:24:55 AM
Kadmon Corporation Presents Preclinical Data On KD025 In Chronic Graft-Versus-Host-Disease At American Society of Hematology Annual Meeting 12/10/2014 11:34:50 AM